معرفی
Daphne Hompes serves as Professor and Head of the Surgical Oncology unit within the Department of Oncology at KU Leuven's Faculty of Medicine. She holds significant leadership roles including membership on the UZ Leuven Executive Board, the Faculty of Medicine Council and Board, and the Department of Oncology Council, while also contributing to the LKI - KU Leuven Cancer Institute and Biomedical Sciences Group Evaluation Committee.
Her research centers on surgical oncology with intensive focus on sarcoma subtypes (dermatofibrosarcoma protuberans, liposarcoma, malignant peripheral nerve sheath tumors), vascular access device outcomes, neurofibromatosis type 1 management, and neuroblastoma surgical risk assessment. She leads international collaborations examining biopsy techniques, diagnostic pathways, and patient-centered outcomes in rare tumor management, with particular emphasis on translational applications.
Analysis of her ten 2025 publications reveals dominant themes in international sarcoma research collaboration, spanning biopsy technique optimization, vascular access device evaluation, and standardized risk assessment tools. Her work appears predominantly in high-impact surgical oncology journals (Annals of Surgical Oncology), specialized cancer journals (Cancers), and discipline-specific publications covering vascular access, radiology, and pediatric surgery, demonstrating cross-disciplinary impact.
No scientific awards were documented in the provided information.
Dr. Hompes currently co-promotes two major research projects: 'Contemporary view and new insights in mid–and long term vascular access' (2021-2025) and 'Exploring the biology and drug sensitivity of selected mesenchymal malignancies' (2020-2024). While specific students aren't listed, her leadership in multi-institutional studies involving numerous co-authors suggests active mentorship of junior researchers within the KU Leuven Cancer Institute framework.
As head of Surgical Oncology at UZ Leuven and integral member of the LKI - KU Leuven Cancer Institute, she directs a multidisciplinary team focused on improving sarcoma management through clinical innovation, vascular access optimization, and international protocol development, with strong connections to European sarcoma centers through the European Organisation for Research and Treatment of Cancer (EORTC) network.
